Insider Trading July 9, 2026 04:18 PM

Legacy Education Executive Reduces Holdings Through Trust Structure

CEO LeeAnn Rohmann's indirect sale of 5,000 shares highlights ongoing executive activity as the firm navigates post-earnings market dynamics.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
LGCY

Legacy Education Inc. (NASDAQ:LGCY) Chief Executive Officer LeeAnn Rohmann executed an indirect sale of 5,000 shares of the company's common stock on July 8, 2026, resulting in total proceeds of $57,502. The transaction was facilitated through The LeeAnn Rollings Rohmann Trust U/A DTD 03/24/2025, where Rohmann serves as the Trustee. Following this divestment, her indirect ownership position in Legacy Education common stock remains at 883,123 shares. The sale occurred at prices ranging from $11.39 to $11.5950 per share, yielding a weighted average sale price of $11.5005. This executive activity takes place as Legacy Education trades at $11.67, carrying a market capitalization of $147.9 million. Market analysis suggests the stock may be undervalued, with comprehensive Fair Value assessments available to subscribers.

Legacy Education Executive Reduces Holdings Through Trust Structure
LGCY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO LeeAnn Rohmann sold 5,000 shares indirectly through a trust, reducing her stake while maintaining significant ownership at 883,123 shares.
  • The sale occurred at a weighted average price of $11.5005, contributing to a total transaction value of $57,502.
  • Legacy Education reported increased revenue and EPS for Q3 fiscal 2026, yet the stock declined in aftermarket trading, trading at $11.67 with a $147.9 million market cap.

Legacy Education Inc. (NASDAQ:LGCY) Chief Executive Officer LeeAnn Rohmann has reduced her indirect stake in the company through a recent transaction. According to regulatory filings, Rohmann sold 5,000 shares of Legacy Education's common stock on July 8, 2026. The total value generated from this sale was $57,502.

The execution of this sale occurred through a specific trust structure. The LeeAnn Rollings Rohmann Trust U/A DTD 03/24/2025 facilitated the transaction, with Ms. Rohmann acting in her capacity as the Trustee. The shares were transacted at prices fluctuating between $11.39 and $11.5950 per share. This range resulted in a weighted average sale price of $11.5005. Despite this reduction, Ms. Rohmann's indirect ownership position in Legacy Education common stock remains substantial at 883,123 shares.

This insider activity unfolds against the backdrop of Legacy Education's current market valuation. The stock is trading at $11.67, which corresponds to a market capitalization of $147.9 million. Independent analysis indicates that the stock appears undervalued at these current levels. Subscribers to comprehensive financial platforms have access to detailed Fair Value assessments and exclusive insights regarding LGCY.

Further context is provided by Legacy Education's recent financial reporting. The company disclosed its third-quarter fiscal 2026 earnings on May 14. The report highlighted a notable increase in both revenue and earnings per share (EPS). Despite these positive financial metrics, the stock experienced a decline in aftermarket trading following the earnings release. These developments underscore the company's recent financial performance trajectory.

At the time of this reporting, there were no other significant updates regarding the company. No mergers, analyst upgrades, or downgrades have been reported alongside this insider transaction. The focus remains on the executive's indirect divestment and the broader market performance of Legacy Education.

Risks

  • Post-earnings stock decline despite improved financial metrics suggests potential market skepticism or valuation pressure in the education sector.
  • Heavy reliance on executive trust structures for transactions may obscure direct ownership visibility for investors monitoring insider activity.

More from Insider Trading

Oregon Community Foundation Reduces Stake in Jewett Cameron Trading Co Jul 9, 2026 HRT Financial Disposes of Shuttle Pharmaceuticals Holdings Amid Merger Activity and Stock Split Jul 9, 2026 HRT Financial Reduces Wheeler REIT Stake Amid Portfolio Restructuring Jul 9, 2026 Immunome Executive Liquidates Position as Pipeline Developments Advance Jul 9, 2026 AtaiBeckley Director Robert Hershberg Executes Pre-Arranged Sale Following Option Exercises Jul 9, 2026